As the demand for specialized therapies like mRNA, gene therapy, and biologics grows, CDMOs are investing in state-of-the-art facilities and technical expertise to support high-complexity drug development and manufacturing under strict regulatory oversight. https://www.marketresearchfuture.com/reports/cmo-cdmo-market-21874